Original Research
Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes
Joanne Sloan-Lancaster, Eyas Abu-Raddad, John Polzer, Jeffrey W. Miller, Joel C. Scherer, Andrea De Gaetano, Jolene K. Berg, William H. Landschulz